Sherbrooke Park Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Buy |
+24,678
| New | +$1.36M | 0.59% | 11 |
|
|
2025
Q1 | – | Sell |
-5,510
| Closed | -$362K | – | 632 |
|
|
2024
Q4 | $362K | Buy |
+5,510
| New | +$362K | 0.12% | 319 |
|
|
2024
Q3 | – | Sell |
-7,488
| Closed | -$616K | – | 930 |
|
|
2024
Q2 | $616K | Buy |
7,488
+2,820
| +60% | +$232K | 0.11% | 322 |
|
|
2024
Q1 | $408K | Buy |
+4,668
| New | +$408K | 0.08% | 440 |
|
|
2023
Q4 | – | Sell |
-12,515
| Closed | -$1.11M | – | 472 |
|
|
2023
Q3 | $1.11M | Buy |
+12,515
| New | +$1.11M | 0.35% | 86 |
|